Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 26Gastrointestinal 20Thoracic 12Genitourinary 12Dermatologic 12Gynecologic 10Breast 10Sarcoma 8Head & Neck 5Lymphoid 4CNS 4Other hematologic neoplasm 3Endocrine 2Plasma cell 1NET 1Myeloid 1Classical hematology 1

Conditions

Neuroendocrine Tumors 7Pheochromocytoma 4Paraganglioma 4Adrenocortical Carcinoma 4Thyroid Neoplasms 3Thyroid Cancer, Papillary 3Adenocarcinoma, Follicular 3Neoplasm Metastasis 2Adenoma, Islet Cell 2Vulvar Neoplasms 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Seminoma 1Rare Diseases 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Perivascular Epithelioid Cell Neoplasms 1Parathyroid Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Paget Disease, Extramammary 1Non functioning pancreatic endocrine tumor 1Neurofibrosarcoma 1Nasopharyngeal Carcinoma 1Multiple Sclerosis 1Mouth Neoplasms 1Metastatic Digestive System Neuroendocrine Tumor G1 1Melanoma 1

Interventions

Doxorubicin 4Sunitinib 3Radiosurgery 3Everolimus 3pembrolizumab 2exemestane 2Tamoxifen 2Specimen Handling 2Octreotide 2Magnetic Resonance Spectroscopy 2Fulvestrant 2Filgrastim 2Biopsy 2Bevacizumab 23-Iodobenzylguanidine 2tislelizumab 1surufatinib 1romidepsin 1regorafenib 1penpulimab 1pasireotide 1mercaptoundecahydrododecaborate 1lutetium Lu 177 dotatate 1lanreotide 1ganitumab 1folfirinox 1fludarabine phosphate 1epothilone B 1entrectinib 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Specimen Handling × Endocrine × Clear all
NCT04514497 2026-06-02

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
29 enrolled 25 charts
EndocrineGastrointestinalThoracic

Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡